<SEC-DOCUMENT>0000785161-21-000027.txt : 20210511
<SEC-HEADER>0000785161-21-000027.hdr.sgml : 20210511
<ACCEPTANCE-DATETIME>20210510194018
ACCESSION NUMBER:		0000785161-21-000027
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210506
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Regulation FD Disclosure
FILED AS OF DATE:		20210511
DATE AS OF CHANGE:		20210510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Encompass Health Corp
		CENTRAL INDEX KEY:			0000785161
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				630860407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10315
		FILM NUMBER:		21909129

	BUSINESS ADDRESS:	
		STREET 1:		9001 LIBERTY PARKWAY
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242
		BUSINESS PHONE:		205-967-7116

	MAIL ADDRESS:	
		STREET 1:		9001 LIBERTY PARKWAY
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH CORP
		DATE OF NAME CHANGE:	19950113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH REHABILITATION CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ehc-20210506.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:9b2cec4d-c839-4ef6-876f-d305c2dac911,g:9402905a-a260-4c6b-a7eb-2f96c73b5dde,d:05d8dc1f3ad042ca863d4c331f7c3af6--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ehc-20210506</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl80L2ZyYWc6ZDhhODZjNTRlODI4NDFlMmFiMjQyYjZkYmE1ODE0ODAvdGFibGU6NDA0N2YxOWRhNjNkNDMxNWI2YTUxMWZiYjA5N2RhNGEvdGFibGVyYW5nZTo0MDQ3ZjE5ZGE2M2Q0MzE1YjZhNTExZmJiMDk3ZGE0YV8wLTEtMS0xLTA_b1b4dff5-1813-4e90-b79f-db0a3b768f39">false</ix:nonNumeric><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl80L2ZyYWc6ZDhhODZjNTRlODI4NDFlMmFiMjQyYjZkYmE1ODE0ODAvdGFibGU6NDA0N2YxOWRhNjNkNDMxNWI2YTUxMWZiYjA5N2RhNGEvdGFibGVyYW5nZTo0MDQ3ZjE5ZGE2M2Q0MzE1YjZhNTExZmJiMDk3ZGE0YV8xLTEtMS0xLTA_d5075045-0c04-42c1-820f-a8503fd0992e">0000785161</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ehc-20210506.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000785161</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-06</xbrli:startDate><xbrli:endDate>2021-05-06</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i05d8dc1f3ad042ca863d4c331f7c3af6_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjY4_fd20416c-f4c4-4af6-80ca-540a78a19cd1">8-K</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported): <ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8yMjY_c79ec39e-4786-4bb1-a118-75db4f916965">May 6, 2021</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:28pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjYz_3408921b-54a4-495d-9c34-0491cf864c43">Encompass Health Corporation</ix:nonNumeric> </span></div><div style="margin-top:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its Charter)</span></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjcy_69960ce5-562f-498c-899d-22d88f081ef6">Delaware</ix:nonNumeric> </span></div><div style="margin-top:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or Other Jurisdiction of Incorporation)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6ZDgyZjllMDdhNGFiNDA0NWIyY2MwNjVjODMxMmZmYmUvdGFibGVyYW5nZTpkODJmOWUwN2E0YWI0MDQ1YjJjYzA2NWM4MzEyZmZiZV8wLTAtMS0xLTA_f8501c86-943c-4ebe-b300-9315a38146d4">001-10315</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6ZDgyZjllMDdhNGFiNDA0NWIyY2MwNjVjODMxMmZmYmUvdGFibGVyYW5nZTpkODJmOWUwN2E0YWI0MDQ1YjJjYzA2NWM4MzEyZmZiZV8wLTEtMS0xLTA_d598d688-93c6-4ffd-83ed-f49122dd9773">63-0860407</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjY5_6b41eaaf-bf4c-44d4-910e-863aa18e7b77">9001 Liberty Parkway</ix:nonNumeric>, <ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjY0_dca7f5d4-4e27-4949-9ec7-b097476e2292">Birmingham</ix:nonNumeric>, <ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjcw_522bd47f-c72a-4880-b729-587052a46553">Alabama</ix:nonNumeric> <ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjcx_da854fbf-8349-46a5-aa39-f63ae0d016c5">35242</ix:nonNumeric> </span></div><div style="margin-top:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices, Including Zip Code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjY1_ef37b8c1-16cb-423e-847a-09e0657c6047">205</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjY2_6fa88e90-0f1b-4d35-8949-8a6cabe2fe67">967-7116</ix:nonNumeric> </span></div><div style="margin-top:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6OTFlZTMxMDY4MTdiNDk4OTgxNzk0MWU4OGQ2Y2I4NzMvdGFibGVyYW5nZTo5MWVlMzEwNjgxN2I0OTg5ODE3OTQxZTg4ZDZjYjg3M18wLTAtMS0xLTA_1321a5b2-61c1-4b90-b51c-3ee0a79f8dce">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6OTFlZTMxMDY4MTdiNDk4OTgxNzk0MWU4OGQ2Y2I4NzMvdGFibGVyYW5nZTo5MWVlMzEwNjgxN2I0OTg5ODE3OTQxZTg4ZDZjYjg3M18yLTAtMS0xLTA_3a4e67c0-6c71-4079-8cc4-86584da1dd25">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6OTFlZTMxMDY4MTdiNDk4OTgxNzk0MWU4OGQ2Y2I4NzMvdGFibGVyYW5nZTo5MWVlMzEwNjgxN2I0OTg5ODE3OTQxZTg4ZDZjYjg3M180LTAtMS0xLTA_20e29768-dcab-4dd0-8085-e13d5c4a5f09">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6OTFlZTMxMDY4MTdiNDk4OTgxNzk0MWU4OGQ2Y2I4NzMvdGFibGVyYW5nZTo5MWVlMzEwNjgxN2I0OTg5ODE3OTQxZTg4ZDZjYjg3M182LTAtMS0xLTA_eba5a492-0ec4-4799-b92c-d66507f67111">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. &#160;&#160;&#160;&#160;Emerging growth company&#160;&#160;      <ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjY3_85de35bf-472a-49a9-8fef-3c45d3e43da8">&#9744;</ix:nonNumeric> </span></div><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange   Act. &#9744;</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"></td><td style="width:37.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6NWRmNDFlODczYWQ1NGY0Njk0NjUxZDRhZmUxOWQ2MjcvdGFibGVyYW5nZTo1ZGY0MWU4NzNhZDU0ZjQ2OTQ2NTFkNGFmZTE5ZDYyN18xLTAtMS0xLTA_e1f63419-b53c-464e-aa1b-49fc007d126f">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6NWRmNDFlODczYWQ1NGY0Njk0NjUxZDRhZmUxOWQ2MjcvdGFibGVyYW5nZTo1ZGY0MWU4NzNhZDU0ZjQ2OTQ2NTFkNGFmZTE5ZDYyN18xLTEtMS0xLTA_810dbcf2-616d-4010-948a-bc133c4e499f">EHC</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6NWRmNDFlODczYWQ1NGY0Njk0NjUxZDRhZmUxOWQ2MjcvdGFibGVyYW5nZTo1ZGY0MWU4NzNhZDU0ZjQ2OTQ2NTFkNGFmZTE5ZDYyN18xLTItMS0xLTA_9fac7c1b-9c05-4986-a671-8dfddf090109">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i05d8dc1f3ad042ca863d4c331f7c3af6_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.07. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Submission of Matters to a Vote of Security Holders.</span></div><div style="margin-bottom:12pt;margin-top:13.5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 6, 2021,  Encompass Health Corporation (the &#8220;Company&#8221;) held its 2021 annual meeting of stockholders (the &#8220;Annual Meeting&#8221;) at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.virtualshareholdermeeting.com/EHC2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the Annual Meeting, the stockholders of the Company voted on the following proposals:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">election of all 14 persons nominated by the Company&#8217;s board of directors; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">ratification of PricewaterhouseCoopers LLP as the Company&#8217;s independent registered public accounting firm; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">approval of the compensation of the Company&#8217;s named executive officers, as disclosed in the proxy statement filed on March 26, 2021 pursuant to the compensation disclosure rules of the Securities and Exchange Commission.</span></div><div style="margin-bottom:12pt;margin-top:13.5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the record date for the Annual Meeting, there were 99,551,380 shares of the Company&#8217;s common stock issued and outstanding. Each share of common stock was entitled to one vote on each matter properly brought before the Annual Meeting. The common stock voted together as a class. Votes representing 90.2% of the combined voting power of the common stock were represented by proxy at the Annual Meeting.</span></div><div style="margin-bottom:12pt;margin-top:13.5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final voting results for the Annual Meeting were as follows:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 1, election of directors, each of the nominees was elected:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.970%"><tr><td style="width:1.0%"></td><td style="width:37.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.913%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Nominee</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Against</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Abstained</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greg D. Carmichael</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,277,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,095</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John W. Chidsey</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,698,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,144,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,954</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald L. Correll</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,808,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,487</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yvonne M. Curl</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,104,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,742,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,874</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles M. Elson</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,672,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,172,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,167</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joan E. Herman</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,671,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,822</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leo I. Higdon, Jr.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,342,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,503,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,744</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leslye G. Katz</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,166,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,128</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patricia A. Maryland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,708,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,087</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John E. Maupin, Jr.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,771,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,954</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nancy M. Schlichting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,691,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,899</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L. Edward Shaw, Jr.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,987,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,858,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,363</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Tarr</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,963,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,303</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terrance Williams</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,705,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,661</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 2, ratification of the appointment of PricewaterhouseCoopers LLP as the Company&#8217;s independent registered public accounting firm, passed:</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.730%"><tr><td style="width:1.0%"></td><td style="width:30.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.924%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes Abstained</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,892,551</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911,316</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,880</span></td></tr></table></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 3, approval of the compensation of the Company&#8217;s named executive officers, passed:</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.730%"><tr><td style="width:1.0%"></td><td style="width:30.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes Abstained</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,575,257</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257,385</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,896</span></td></tr></table></div><div style="margin-bottom:10pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proposals 1 and 3 each received 4,956,209 broker non-votes. There were no broker non-votes on Proposal 2.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i05d8dc1f3ad042ca863d4c331f7c3af6_1099511627917"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7.01.&#160;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulation FD Disclosure.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will participate in the BofA Securities Virtual Health Care Conference being held on May 11-13, 2021. Encompass Health President and Chief Executive Officer, Mark Tarr, and Executive Vice President and Chief Financial Officer, Doug Coltharp, will participate in a fireside chat at 2:00 p.m. ET on Tuesday, May 11, 2021. The presentation will be webcast live and will be available at http://investor.encompasshealth.com by clicking on an available link.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this conference, the Company is providing current volume observations for both of its segments. For the second quarter of 2021, the Company expects to report strong volume growth since volumes were most significantly impacted by COVID-19 in the second quarter of 2020. </span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the inpatient rehabilitation segment, for the month of April 2021, the Company experienced a 31.9% increase in same-store discharges compared to April 2020 and a 2.7% increase when compared to April 2019. The Company believes that elective procedures are beginning to return in many markets. In April 2019, the Company discharged approximately 1,860 orthopedic and lower extremity joint replacement patients. In April 2020, that number dropped to approximately 870. In April 2021, the Company discharged approximately 1,610 of these patients.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to see encouraging signs of volume recovery in its home health business. Admissions of patients following elective procedures in acute care hospitals have been steadily increasing each month of 2021. Access to skilled nursing facilities and assisted living facilities continues to improve, but the Company has not experienced meaningful increase in volumes due to the lower censuses at these facilities. Volumes from the new contract with United Healthcare were consistent sequentially from March to April at approximately 1,500 non-episodic admissions, which compares to approximately 600 United Healthcare episodic admissions per month during 2020. The Company estimates lost admissions due to the winter storms in February 2021 reduced recertifications in April by approximately 400.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average length of stay for hospice patients in April 2021 increased, but the Company believes it is too early to determine whether that is a reversal of the lower length of stay trend experienced during COVID-19. On a year-to-date basis, the hospice average length of stay was 99 days. For April, it was 110 days.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reiterates as of the date hereof its guidance previously reported in the Current Report on Form 8-K, dated April 27, 2021, and during the Company's earnings conference call held on April 28, 2021. Accordingly, the Company continues to expect the following full-year 2021 ranges:</span></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net operating revenues of $5,060 million to $5,230 million;</span></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA of $1,000 million to $1,030 million; and</span></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted earnings per share from continuing operations attributable to Encompass Health of $3.94 to $4.16.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses &#8220;same-store&#8221; comparisons to explain the changes in certain performance metrics and line items within its financial statements. Same-store comparisons are calculated based on hospitals and home health and hospice locations open throughout both the full current and prior periods presented. These comparisons include the financial results of market consolidation transactions in existing markets, as it is difficult to determine, with precision, the incremental impact of these transactions on the Company&#8217;s results of operations.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained herein is being furnished pursuant to Item 7.01 of Form 8-K, &#8220;Regulation FD Disclosure.&#8221; This information shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The furnishing of this information will not be deemed an admission as to the materiality of any information contained herein.</span></div><div style="margin-bottom:12pt;margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Note Regarding Presentation of Non-GAAP Financial Measures</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding net operating revenues, the Company does not provide guidance on a generally accepted accounting principles in the United States (&#8220;GAAP&#8221;) basis because it is unable to predict, with reasonable certainty, the future impact of items that are deemed to be outside the control of the Company or otherwise non-indicative of its ongoing operating performance. Such items include government, class action, and related settlements; professional fees&#8212;accounting, tax, and legal; mark-to-market adjustments for stock appreciation rights; gains or losses related to hedging and equity instruments; loss on early extinguishment of debt; adjustments to its income tax provision (such as valuation allowance adjustments, settlements of income tax claims and windfall tax benefits); items related to corporate and facility restructurings; and certain other items the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company believes to be non-indicative of its ongoing operating performance. These items cannot be reasonably predicted, will depend on several factors, including industry and market conditions, and could be material to the Company&#8217;s results computed in accordance with GAAP.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, the following reasonably estimable GAAP measures for 2021 would be included in a reconciliation for Adjusted EBITDA if the other reconciling GAAP measures could be reasonably predicted:</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;      Interest expense and amortization of debt discounts and fees - estimate of $164 million to $174 million</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;      Amortization of debt-related items - approximately $9 million</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides adjusted earnings per share from continuing operations attributable to Encompass Health (&#8220;adjusted earnings per share&#8221;). The Company believes the presentation of adjusted earnings per share provides useful additional information to investors because it provides better comparability of ongoing operating performance to prior periods given that it excludes the impact of government, class action, and related settlements; professional fees&#8212;accounting, tax, and legal; mark-to-market adjustments for stock appreciation rights; gains or losses related to hedging and equity instruments; loss on early extinguishment of debt; adjustments to its income tax provision (such as valuation allowance adjustments, settlements of income tax claims and windfall tax benefits); items related to corporate and facility restructurings; and certain other items the Company believes to be non-indicative of its ongoing operating performance. It is reasonable to expect that one or more of these excluded items will occur in future periods, but the amounts recognized can vary significantly from period to period and may not directly relate to the Company&#8217;s ongoing operating performance. Accordingly, they can complicate comparisons of the Company&#8217;s results of operations across periods and comparisons of the Company&#8217;s results to those of other healthcare companies. Adjusted earnings per share should not be considered as a measure of financial performance under GAAP as the items excluded from it are significant components in understanding and assessing financial performance. Because adjusted earnings per share is not a measurement determined in accordance with GAAP and is thus susceptible to varying calculations, it may not be comparable as presented to other similarly titled measures of other companies.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses Adjusted EBITDA on a consolidated basis as a liquidity measure. The Company believes this financial measure on a consolidated basis is important in analyzing its liquidity because it is the key component of certain material covenants contained within the Company&#8217;s credit agreement, which is discussed in more detail in Item 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Liquidity and Capital Resources,&#8221; and Note&#160;10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the consolidated financial statements included in its Annual Report on Form 10&#8209;K for the year ended December&#160;31, 2020 (the &#8220;2020 Form 10&#8209;K&#8221;). These covenants are material terms of the credit agreement. Noncompliance with these financial covenants under the credit agreement&#8212;its interest coverage ratio and its leverage ratio&#8212;could result in the Company&#8217;s lenders requiring the Company to immediately repay all amounts borrowed. If the Company anticipated a potential covenant violation, it would seek relief from its lenders, which would have some cost to the Company, and such relief might be on terms less favorable to those in the Company&#8217;s existing credit agreement. In addition, if the Company cannot satisfy these financial covenants, it would be prohibited under the credit agreement from engaging in certain activities, such as incurring additional indebtedness, paying common stock dividends, making certain payments, and acquiring and disposing of assets. Consequently, Adjusted EBITDA is critical to the Company&#8217;s assessment of its liquidity.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general terms, the credit agreement definition of Adjusted EBITDA, therein referred to as &#8220;Adjusted Consolidated EBITDA,&#8221; allows the Company to add back to consolidated net income interest expense, income taxes, and depreciation and amortization and then add back to consolidated net income (1)&#160;all unusual or nonrecurring items reducing consolidated net income (of which only up to $10 million in a year may be cash expenditures), (2)&#160;any losses from discontinued operations, (3)&#160;non-ordinary course fees, costs and expenses incurred with respect to any litigation or settlement, (4)&#160;share-based compensation expense, (5) costs and expenses associated with changes in the fair value of marketable securities, (6) costs and expenses associated with the issuance or prepayment debt and acquisitions, and (7) any restructuring charges not in excess of 20% of Adjusted Consolidated EBITDA. The Company also subtracts from consolidated net income all unusual or nonrecurring items to the extent they increase consolidated net income.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of Adjusted EBITDA under the credit agreement does not require us to deduct net income attributable to noncontrolling interests or&#160;gains on fair value adjustments of hedging and equity instruments, disposal of assets, and development activities. It also does not allow us to add back losses on fair value adjustments of hedging instruments or&#160;unusual or nonrecurring cash expenditures in excess of $10 million. These items and amounts, in addition to the items falling within the credit agreement&#8217;s &#8220;unusual or nonrecurring&#8221; classification, may occur in future periods, but can vary significantly from period to period and may not directly relate to, or be indicative of, the Company's ongoing liquidity or operating performance. Accordingly, the Adjusted EBITDA calculation presented here includes adjustments for them.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is not a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Therefore, Adjusted EBITDA should not be considered a substitute for net income or cash flows from operating, investing, or financing activities. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is thus susceptible to varying calculations, Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. Revenues and expenses are measured in accordance with the policies and procedures described in Note&#160;1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the consolidated financial statements accompanying the 2020 Form 10-K.</span></div><div style="margin-bottom:10pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in this Current Report on Form 8-K&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to various risks and uncertainties and include all statements that are not historical statements of fact and those regarding the Company&#8217;s intent, belief or expectations, including statements and assumptions regarding the nature of the COVID-19 pandemic, its impact on the Company&#8217;s results of operations, cash flow and liquidity, actions to be taken by the Company in response to the pandemic, including the review of strategic alternatives for its home health and hospice business, financial guidance, and the demand for the Company&#8217;s services. These forward-looking statements are based on certain assumptions and expectations, and the Company&#8217;s ability to predict results or the actual effect of future actions, plans or strategies, or the spread and impact of COVID-19 is inherently uncertain. Actual results and performance could differ materially. Factors which could have a material adverse effect on the Company&#8217;s operations and future prospects or which could cause events or circumstances to differ from the forward-looking statements include, but are not limited to, the possibility that the Company may not be able to realize higher values for its home health and hospice business through strategic transactions; the possibility that the Company may decide not to undertake a transaction following the review of strategic alternatives or that it is not able to consummate any proposed transactions resulting from the review due to, among other things, market, regulatory and other factors; the potential for disruption to the Company's business resulting from the review of strategic alternatives or the undertaking of any transactions following the review; the continued spread of COVID-19, including the speed, depth, geographic reach and duration of the spread, which could decrease our patient volumes and revenues and lead to staffing and supply shortages and associated cost increases; actions to be taken by the Company in response to the pandemic; the legal, regulatory and administrative developments that occur at the federal, state and local levels; the Company&#8217;s infectious disease prevention and control efforts; the demand for the Company&#8217;s services, including based on any downturns in the economy, consumer confidence, or the capital markets and unemployment among family members; the price of the Company's common stock as it affects the Company&#8217;s willingness and ability to repurchase shares and the financial and accounting effects of any repurchases; any adverse effects on the Company&#8217;s stock price resulting from the integration of acquired operations; the Company&#8217;s ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages, which may be worsened by the pandemic, and the impact on the Company&#8217;s labor expenses from potential union activity and staffing shortages; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of the Company&#8217;s or its vendors&#8217; or partners&#8217; information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information or inability to provide patient care because of system unavailability as well as unforseen issues, if any, related to integration of acquired systems; the ability to successfully integrate acquired operations, including realization of anticipated tax benefits, revenues, and cost savings, minimizing the negative impact on margins arising from the changes in staffing and other operating practices, and avoidance of unforeseen exposure to liabilities; the Company's ability to successfully complete and integrate de novo developments, acquisitions, investments, and joint ventures consistent with its growth strategy; increases in Medicare audit activity, including increased use of sampling and extrapolation, resulting in additional unpaid reimbursement claims and an increase in the backlog of appealed claims denials; the Company&#8217;s ability to comply with extensive, complex, and ever-changing federal, state and local regulations and sub-regulatory guidance in both business in general, such as privacy and wage and hour regulations, and in the healthcare industry specifically; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving the Company, including any matters related to yet undiscovered issues, if any, in acquired operations; the Company&#8217;s ability to attract and retain key management personnel; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for the Company&#8217;s services by governmental or private payors; changes in the regulation of the healthcare industry at either or both of the federal and state levels, including as part of national healthcare reform and deficit reduction (such as payment system reforms) and the Company&#8217;s ability to adapt operations to those changes; competitive pressures in the healthcare industry and the Company's response thereto; the Company's ability to obtain and retain favorable arrangements with third-party payors; the Company&#8217;s ability to control costs, particularly labor and employee benefit costs, including group medical expenses; adverse effects resulting from coverage determinations made by Medicare Administrative Contractors regarding its Medicare reimbursement claims and lengthening delays in the Company's ability to recover improperly denied claims through the administrative appeals process on a timely basis; the Company's ability to adapt to changes in the healthcare delivery system, including value-based purchasing and involvement in coordinated care initiatives or programs that may arise with its referral sources; the Company&#8217;s ability to maintain proper local, state and federal licensing, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including compliance with the Medicare conditions of participation and provider enrollment requirements, which is required to participate in the Medicare program; and changes in the Company&#8217;s payor mix or the acuity of its patients affecting reimbursement rates; general conditions in the economy and capital markets, including any instability or uncertainty related to armed conflict or an act of terrorism, governmental impasse over approval of the United States federal budget, an increase in the debt ceiling, or an international sovereign debt crisis; the increase in the costs of defending and insuring against alleged professional liability claims, including claims associated with patient and employee exposures to COVID-19, and Encompass Health's ability to predict the estimated costs related to such claims; as well as other risks detailed from time to time in Encompass Health&#8217;s SEC filings and other public announcements, including its Form 10&#8209;K for the year ended December 31, 2020 and Form 10-Q for the quarter ended March 31, 2021.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When considering forward-looking statements, readers should keep in mind the risk factors and other cautionary statements in such SEC filings. Readers are cautioned not to place undue reliance on any of these forward-looking statements, which reflect management's views as of the date of this presentation. The Company cannot guarantee future results, levels of activity, performance or achievements, and, except as required by law, it expressly disclaims any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations with regard thereto or change in events, conditions or circumstances on which any statement is based.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i05d8dc1f3ad042ca863d4c331f7c3af6_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;padding-left:108pt;text-align:right"><span><br/></span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.701%"><tr><td style="width:1.0%"></td><td style="width:7.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.691%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ENCOMPASS HEALTH CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160;&#160; D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OUGLAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> E. C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OLTHARP</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Douglas E. Coltharp</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div style="margin-bottom:10pt;text-align:right"><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: May 10, 2021</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>ehc-20210506.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9b2cec4d-c839-4ef6-876f-d305c2dac911,g:9402905a-a260-4c6b-a7eb-2f96c73b5dde-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ehc="http://www.encompasshealth.com/20210506" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.encompasshealth.com/20210506">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20210506_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20210506_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20210506_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20210506_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.encompasshealth.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>3
<FILENAME>ehc-20210506_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9b2cec4d-c839-4ef6-876f-d305c2dac911,g:9402905a-a260-4c6b-a7eb-2f96c73b5dde-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.encompasshealth.com/role/Cover" xlink:type="simple" xlink:href="ehc-20210506.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.encompasshealth.com/role/Cover" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>ehc-20210506_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9b2cec4d-c839-4ef6-876f-d305c2dac911,g:9402905a-a260-4c6b-a7eb-2f96c73b5dde-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.encompasshealth.com/role/Cover" xlink:type="simple" xlink:href="ehc-20210506.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.encompasshealth.com/role/Cover" xlink:type="extended" id="i64378c7c2947408aa3bdf65ef5202e94_Cover"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>ehc-20210506_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9b2cec4d-c839-4ef6-876f-d305c2dac911,g:9402905a-a260-4c6b-a7eb-2f96c73b5dde-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_e741bd05-e690-48a4-a3b8-9de280399667_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2ddf49f5-a3c7-4c78-8c2a-20e006f10d87_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_ad5bc900-d338-4793-aae9-82a6cfa13072_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_686c5b9a-fcce-425a-b026-f84bde015853_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_f8af391f-164b-4ae9-8ea2-13502c7755ca_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_0439ff1f-076a-4877-ab0c-149e2f7699e8_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_478d8927-a237-4138-b77b-8da42703e152_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_023dddb6-6822-4735-871a-f7efce3a5f31_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d64b3925-3673-4903-9940-9310b5090b14_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_d8d98dc8-1b8b-4d77-815b-e5678a71a48d_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e969990c-eeef-4041-8fb7-559b91a7ce3d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_38cb0fbd-5fea-4a89-822d-d74b0fc00697_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_22de175c-1a4e-4b84-9347-6f3f7a7d81e4_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_d4fba324-cc39-481c-8a04-ac51c4e9f2c4_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_aecbdcf6-c443-427c-9fb3-2b842ddfe821_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_7d47116e-a822-455f-a4fe-d7bcc09a4712_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fa1df54c-21ed-4483-bf2d-4dbb23274bcf_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_41a99f81-2148-4646-926d-97ee950f981c_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_596954d3-e2be-4baf-86de-fc5bb74ff921_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_28c63158-364e-4820-9427-45f7f2276b58_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ebf5b0ef-243c-42c4-972e-8d1504932ab1_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_8d932d89-a6a3-4cfd-8f40-8960ebfa0415_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>ehc-20210506_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9b2cec4d-c839-4ef6-876f-d305c2dac911,g:9402905a-a260-4c6b-a7eb-2f96c73b5dde-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.encompasshealth.com/role/Cover" xlink:type="simple" xlink:href="ehc-20210506.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.encompasshealth.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_98d9bbdd-3c28-4916-8c6c-29fee5bf4d5a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_DocumentType_98d9bbdd-3c28-4916-8c6c-29fee5bf4d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a65d9a75-8df6-4fc9-9173-09848be19ed5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_DocumentPeriodEndDate_a65d9a75-8df6-4fc9-9173-09848be19ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_97d17430-64b1-405f-b29e-6d0f397702ea" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_EntityRegistrantName_97d17430-64b1-405f-b29e-6d0f397702ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2d354ef1-5561-4243-afe6-4004a6051314" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2d354ef1-5561-4243-afe6-4004a6051314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_42de1e77-cf4b-44aa-bac6-1def4d43ebf1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_EntityFileNumber_42de1e77-cf4b-44aa-bac6-1def4d43ebf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3dc3f7da-124b-48ae-9f06-16eed93abd76" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_EntityTaxIdentificationNumber_3dc3f7da-124b-48ae-9f06-16eed93abd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0b367198-3fc7-4d24-8bca-f25a7ca97da6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_EntityAddressAddressLine1_0b367198-3fc7-4d24-8bca-f25a7ca97da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9c5d4982-d5c3-40a2-abba-5921ef43bc17" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_EntityAddressCityOrTown_9c5d4982-d5c3-40a2-abba-5921ef43bc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b42ef9dd-d36e-4615-8897-bc72dc0b06f6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_EntityAddressStateOrProvince_b42ef9dd-d36e-4615-8897-bc72dc0b06f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9ef44d1e-2ef7-460e-b136-4a383aa88dd7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_EntityAddressPostalZipCode_9ef44d1e-2ef7-460e-b136-4a383aa88dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6ed1f81e-40f9-4978-80ab-44693c3fc6ff" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_CityAreaCode_6ed1f81e-40f9-4978-80ab-44693c3fc6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f56cd27d-d303-4e11-a11a-093b9ae32ed1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_LocalPhoneNumber_f56cd27d-d303-4e11-a11a-093b9ae32ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_6ccbc7a8-e00c-4aef-8278-b7da050c7f29" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_WrittenCommunications_6ccbc7a8-e00c-4aef-8278-b7da050c7f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_bacae0c1-5535-4255-a485-9783fc502a84" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_SolicitingMaterial_bacae0c1-5535-4255-a485-9783fc502a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_69909df8-5f49-46c5-811c-2e3de4fbca1c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_69909df8-5f49-46c5-811c-2e3de4fbca1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_a147c79b-4ce5-492b-aa80-611abb10089e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_PreCommencementTenderOffer_a147c79b-4ce5-492b-aa80-611abb10089e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8c61271a-84c8-4131-8a02-5a721f4b6906" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_EntityEmergingGrowthCompany_8c61271a-84c8-4131-8a02-5a721f4b6906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5d537ad9-3351-4dfb-898a-cd3c61c6ecfb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_Security12bTitle_5d537ad9-3351-4dfb-898a-cd3c61c6ecfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_6eb59166-a841-49bd-8e76-cb05dcb310ba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_TradingSymbol_6eb59166-a841-49bd-8e76-cb05dcb310ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_37b7e7b1-89a4-4463-9f40-ca01887b85ce" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_SecurityExchangeName_37b7e7b1-89a4-4463-9f40-ca01887b85ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e66532d2-b78a-48f6-bf58-c4f0c7978987" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_AmendmentFlag_e66532d2-b78a-48f6-bf58-c4f0c7978987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b239090f-1050-41c6-b63b-e2a449a041f0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18eb6ffe-85a4-4310-92b7-e31fd153f1b8" xlink:to="loc_dei_EntityCentralIndexKey_b239090f-1050-41c6-b63b-e2a449a041f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>ehc-20210506_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ehc-20210506.xsd" xlink:type="simple"/>
    <context id="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000785161</identifier>
        </entity>
        <period>
            <startDate>2021-05-06</startDate>
            <endDate>2021-05-06</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl80L2ZyYWc6ZDhhODZjNTRlODI4NDFlMmFiMjQyYjZkYmE1ODE0ODAvdGFibGU6NDA0N2YxOWRhNjNkNDMxNWI2YTUxMWZiYjA5N2RhNGEvdGFibGVyYW5nZTo0MDQ3ZjE5ZGE2M2Q0MzE1YjZhNTExZmJiMDk3ZGE0YV8wLTEtMS0xLTA_b1b4dff5-1813-4e90-b79f-db0a3b768f39">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl80L2ZyYWc6ZDhhODZjNTRlODI4NDFlMmFiMjQyYjZkYmE1ODE0ODAvdGFibGU6NDA0N2YxOWRhNjNkNDMxNWI2YTUxMWZiYjA5N2RhNGEvdGFibGVyYW5nZTo0MDQ3ZjE5ZGE2M2Q0MzE1YjZhNTExZmJiMDk3ZGE0YV8xLTEtMS0xLTA_d5075045-0c04-42c1-820f-a8503fd0992e">0000785161</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjY4_fd20416c-f4c4-4af6-80ca-540a78a19cd1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8yMjY_c79ec39e-4786-4bb1-a118-75db4f916965">2021-05-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjYz_3408921b-54a4-495d-9c34-0491cf864c43">Encompass Health Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjcy_69960ce5-562f-498c-899d-22d88f081ef6">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6ZDgyZjllMDdhNGFiNDA0NWIyY2MwNjVjODMxMmZmYmUvdGFibGVyYW5nZTpkODJmOWUwN2E0YWI0MDQ1YjJjYzA2NWM4MzEyZmZiZV8wLTAtMS0xLTA_f8501c86-943c-4ebe-b300-9315a38146d4">001-10315</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6ZDgyZjllMDdhNGFiNDA0NWIyY2MwNjVjODMxMmZmYmUvdGFibGVyYW5nZTpkODJmOWUwN2E0YWI0MDQ1YjJjYzA2NWM4MzEyZmZiZV8wLTEtMS0xLTA_d598d688-93c6-4ffd-83ed-f49122dd9773">63-0860407</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjY5_6b41eaaf-bf4c-44d4-910e-863aa18e7b77">9001 Liberty Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjY0_dca7f5d4-4e27-4949-9ec7-b097476e2292">Birmingham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjcw_522bd47f-c72a-4880-b729-587052a46553">AL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjcx_da854fbf-8349-46a5-aa39-f63ae0d016c5">35242</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjY1_ef37b8c1-16cb-423e-847a-09e0657c6047">205</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjY2_6fa88e90-0f1b-4d35-8949-8a6cabe2fe67">967-7116</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6OTFlZTMxMDY4MTdiNDk4OTgxNzk0MWU4OGQ2Y2I4NzMvdGFibGVyYW5nZTo5MWVlMzEwNjgxN2I0OTg5ODE3OTQxZTg4ZDZjYjg3M18wLTAtMS0xLTA_1321a5b2-61c1-4b90-b51c-3ee0a79f8dce">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6OTFlZTMxMDY4MTdiNDk4OTgxNzk0MWU4OGQ2Y2I4NzMvdGFibGVyYW5nZTo5MWVlMzEwNjgxN2I0OTg5ODE3OTQxZTg4ZDZjYjg3M18yLTAtMS0xLTA_3a4e67c0-6c71-4079-8cc4-86584da1dd25">false</dei:SolicitingMaterial>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6OTFlZTMxMDY4MTdiNDk4OTgxNzk0MWU4OGQ2Y2I4NzMvdGFibGVyYW5nZTo5MWVlMzEwNjgxN2I0OTg5ODE3OTQxZTg4ZDZjYjg3M180LTAtMS0xLTA_20e29768-dcab-4dd0-8085-e13d5c4a5f09">false</dei:PreCommencementIssuerTenderOffer>
    <dei:PreCommencementTenderOffer
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6OTFlZTMxMDY4MTdiNDk4OTgxNzk0MWU4OGQ2Y2I4NzMvdGFibGVyYW5nZTo5MWVlMzEwNjgxN2I0OTg5ODE3OTQxZTg4ZDZjYjg3M182LTAtMS0xLTA_eba5a492-0ec4-4799-b92c-d66507f67111">false</dei:PreCommencementTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGV4dHJlZ2lvbjpmYzc1OGUxZmI5OTM0YThmOTU5ODQzMmI4OTQ5NTg1ZF8xMjY3_85de35bf-472a-49a9-8fef-3c45d3e43da8">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6NWRmNDFlODczYWQ1NGY0Njk0NjUxZDRhZmUxOWQ2MjcvdGFibGVyYW5nZTo1ZGY0MWU4NzNhZDU0ZjQ2OTQ2NTFkNGFmZTE5ZDYyN18xLTAtMS0xLTA_e1f63419-b53c-464e-aa1b-49fc007d126f">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6NWRmNDFlODczYWQ1NGY0Njk0NjUxZDRhZmUxOWQ2MjcvdGFibGVyYW5nZTo1ZGY0MWU4NzNhZDU0ZjQ2OTQ2NTFkNGFmZTE5ZDYyN18xLTEtMS0xLTA_810dbcf2-616d-4010-948a-bc133c4e499f">EHC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if15e1f89a590451686e1031cc952c5ff_D20210506-20210506"
      id="id3VybDovL2RvY3MudjEvZG9jOjA1ZDhkYzFmM2FkMDQyY2E4NjNkNGMzMzFmN2MzYWY2L3NlYzowNWQ4ZGMxZjNhZDA0MmNhODYzZDRjMzMxZjdjM2FmNl8xL2ZyYWc6ZmM3NThlMWZiOTkzNGE4Zjk1OTg0MzJiODk0OTU4NWQvdGFibGU6NWRmNDFlODczYWQ1NGY0Njk0NjUxZDRhZmUxOWQ2MjcvdGFibGVyYW5nZTo1ZGY0MWU4NzNhZDU0ZjQ2OTQ2NTFkNGFmZTE5ZDYyN18xLTItMS0xLTA_9fac7c1b-9c05-4986-a671-8dfddf090109">NYSE</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140472375359352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 06, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  06,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Encompass Health Corporation<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-10315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">63-0860407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9001 Liberty Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Birmingham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">35242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">967-7116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EHC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000785161<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  B=JE('04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  (G:I2P%(APNX    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)^FZ@J';B^))07!!\1:2V=U@TX1DI-VW-XV[740?P&-F_GSS
M#4RK@]0^XG/T 2-93%>3ZX<D==BP U&0 $D?T*E4Y\20FSL?G:+\C'L(2G^H
M/4+#^0TX)&44*9B!55B(K&N-ECJB(A]/>*,7?/B,?8$9#=BCPX$2B%H Z^:)
MX3CU+5P ,XPPNO1=0+,02_5/;.D .R6G9)?4.([UN"JYO(. MZ?'E[)N98=$
M:M"8?R4KZ1APP\Z37U=W]]L'UC6\$15?5X)OQ:V\YE*LWV?7'WX78>>-W=E_
M;'P6[%KX=1?=%U!+ P04    "  (G:I2F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M  B=JE(-Q&/2+ 0  #00   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
ME9A=;^(X%(:O9W^%%>W%KD2;.'QV1)$HI5,T;0<5=D>[J[TPB2%6DSAK.Z7\
M^ST.-&$TX83VHHD3GS>/C^W7-L.M5"\ZXMR0MR1.];43&9-]=ET=1#QA^E)F
M/(4W:ZD29J"H-J[.%&=A$93$KN]Y/3=A(G5&P^+97(V&,C>Q2/E<$9TG"5.[
M&Q[+[;5#G?<'SV(3&?O '0TSMN$+;O[(Y@I*;JD2BH2G6LB4*+Z^=L;T\XW?
ML0%%C3\%W^JC>V*;LI+RQ19FX;7C62(>\\!8"0:75S[A<6R5@.._@ZA3?M,&
M'M^_J]\5C8?&K)CF$QE_%Z&)KIV!0T*^9GELGN7VGA\:U+5Z@8QU\9]L]W4[
M'8<$N38R.00#02+2_96]'1)Q'."="/ / 7[!O?]007G+#!L-E=P296N#FKTI
MFEI$ YQ(;:\LC(*W N+,:")?N1JZ!J3L S<XA-WLP_P388]L1[Q>B_B>3W^,
M=@&@I/!+"K^0:V,4Y)_Q2AL%_?0O(MDN)=N%9.>$Y*T,<A@]ABQW&:]K(!X^
MN/B*0'1*B,YY$'.NA S)- T)=%,M#ZYD$]YK_?+I4T/&NR59%]6;ID:8'7GF
M&V%S#HA/+*GE:M()9)(QK<D]9[&)R$2J3"IFIQR"V2LQ>^=@SN KI6R++ SD
MD$@%'\M3HW9P#6O9<?';*4+8+PG[YQ#>B9B3ISQ9U<\F7,/SZ 7UVK2+\ Q*
MGL$Y/$OV1F8A##VQ%D&1-H0.5^RU+[Q!S^MX?03OJL2[.@=O'(:*:]UZOR$/
M4(]\2VM[$5>\@NQ!.#0-=.=,O6S9#@&E7N6,WH=0)[8$@VXIMVFM8^)R-T*!
M?V\BEF!T1[Y-/T17SHFYDJ\B#6HSV: Y?L#0*C.G_H?0YE(;%I._179RHC8H
MMKM^Q\?8JE6!XKY>=.(8]B^G47 !W\-F*:U6!HH;^H,,("?S2*:8;S2(7/7Z
M%WU*>QA1M2)0W,J_*V$,3R$Q29*G!]?0M52XT)K%FF-(E?M3W*$7,A:!,#!M
MR",,;R587,N#JS3R5%Y/<:.>*WX!ZQTLZ0$OUO69UCGL7)8\#>'R;;T^T8VX
M;"-@9?X4]^J? !O)<+U&LLKWZ5G&/TVXVMC^_ (*Q78!=@_IKA8-%VQ"\RNC
M]W%G7@H#B[=<$^K_MOJ=+'B0PU2H96I0LE,'5MJ%D<%+BV1,D5<6YYS\ZEW"
M(I5!1^B(*92Z6@!\W*R7BH4VD8M=LI*UTZ)!8'H_P4".]NZX.;_GBTS?@HBE
M&WYR*]D@]/37 MN1^97)^[A'CV'HA\7POXO9II8$%V@<6Y7-^[A#'X;]!& 4
M^/T,9N,;^<KK!Q<NY<%??]"EO=K]OWMT!K3GZ4=FYYDF,5^#FG?9!\]6^R/J
MOF!D5AP+5]+ (;.XC>!8SY6M ._74IKW@CUIEC\4C/X'4$L#!!0    (  B=
MJE*?H!OPL0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB
M:N*1&+9 8;"-0O-A7Y58=@1Z\62Y<_KKI[-L)VEU9=V'L<VAR=T]NKM'=R>9
MKEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R
M6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8
MRY20IV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%
ME#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"
M3J9B+7D%=*RHC_#K3), Z)Q17B@%JXUF X?)8Q1\V .7\@%:^*VZBMU7)/3B
M4PEM(+#52?2$1C&$"0K$OXP68E^$O?VML*01C\9][/QN]*!_[XSC]Y97HA_T
MOIKS8]$7>'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY
M85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$
M&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*
M3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?
M@,41P+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S
M/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM
M%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&89
M4IT,/O'^8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$
M4$L#!!0    (  B=JE*7BKL<P    !,"   +    7W)E;',O+G)E;'.=DKEN
MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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MU\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK
M>MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ
M!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.
M\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    (  B=JE('04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ ")VJ4L!2(<+N    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ ")VJ4IE<G",0!@  G"<  !,
M     ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  (G:I2
M#<1CTBP$   T$   &               @($-"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ ")VJ4I^@&_"Q @  X@P   T
M     ( !;PP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  (G:I2EXJ[',
M   3 @  "P              @ %+#P  7W)E;',O+G)E;'-02P$"% ,4
M"  (G:I2JL0B%C,!   B @  #P              @ $T$   >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ ")VJ4B0>FZ*M    ^ $  !H
M ( !E!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
M")VJ4F60>9(9 0  SP,  !,              ( !>1(  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&      D "0 ^ @  PQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ehc-20210506.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.encompasshealth.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ehc-20210506.htm">ehc-20210506.htm</File>
    <File>ehc-20210506.xsd</File>
    <File>ehc-20210506_cal.xml</File>
    <File>ehc-20210506_def.xml</File>
    <File>ehc-20210506_lab.xml</File>
    <File>ehc-20210506_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ehc-20210506.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "ehc-20210506_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ehc-20210506_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ehc-20210506.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ehc-20210506_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ehc-20210506_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ehc-20210506.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ehc",
   "nsuri": "http://www.encompasshealth.com/20210506",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehc-20210506.htm",
      "contextRef": "if15e1f89a590451686e1031cc952c5ff_D20210506-20210506",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.encompasshealth.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehc-20210506.htm",
      "contextRef": "if15e1f89a590451686e1031cc952c5ff_D20210506-20210506",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000785161-21-000027-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000785161-21-000027-xbrl.zip
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M/>-S0UW=GJE:SEV]F1?4=3>7$8ALVX\DH/CT4%=7-;K/#W7]$4.?^RWE=YY
M6\\-=5F@N0RP68\D#O,TJ4QZR^H\#A(_/<S556W3?':8ZSV/E0-06\'0BR-5
M^2-I/3_4U09GQNAV'P<@>)I4-M6.WE:[YDNLZ]YB73WK.SW&-41=[WD:3KGR
MKJ7\R;(OSP]U@=92'>NN0O6"NNY Y6[/4:WN2Z3KWO268=K/#G5]8%D2N %3
M=EJX1V<:UO=:/0]$ -JK1SE&ZW% @J=)9</254OO/0X2/SW4U5;U9YAAI,JN
M?=1<^23X#J=Q?4$!.(V]GJ'JQB.)QCQ-*INJWL/J+N=Q$/DI@J_G6-UUR")W
MBDG&$W<4!NX(-UL^/_#5=0R WH\D"_8TJ6QT.FK'N*OV>@%?*VHO2[4=Y]F!
MK_<M9=^[QC-63D;L^EF"+T-U[)YJ]^[JUKR KSN!+[MCJZ;S2(*+3Q%\M;OM
M9P>^^GA?QA\MY90ER[=1/TTX8+=5I]M6>R^9QGNE,I@'Z\XNXPOH6KE*HJU_
MI]9:0]!URI,$O$:N? K",&#CY9=K/$TP0,'ZCNJT[^HOOD"NN_B+;<SF/A)4
M^_0 EZUVN\:\ZEIP5+9X9?[XXI<SMW[ F5NFJLP>98F';+')) ZBC,XOO/_3
M+?&JCC1=X1BOVLG4C^]"L([>ZK6_[60OO67;]@\_*^N^FK5:CFG=\Q%<S_$H
MJC6<\^QI3L]FWG-'(=U3R. 17G-BVZKMF'C*ZBIWQSR-.3N&H;:-[O.9,&YZ
MM/45\-D+!/M>"-96E1][*/6S!U.Z^>./2;TO,-5I]>P?<KOJ8]4O+V#J!4R]
M@*E;TJ>=7D<U.[UGA"UPNFK;[CR?*5N(F;MW@%.WV^CN#+QZP'/T"QB3*@9=
MG] 6A[4GW.6 2CS%4IU.5S5U!^\_N.2)$L61AM<:I'3=07%M0Q3//<>+%*HX
MU?RM RM%!M?Q.CA#=YR.873-GF.LV]5PIF%V3.=^C$EY-9R(R?=:NM%JAN?O
M:4#4XNJ7Q!WS81X*[/YV3]DK;W)9^>(,_?&(]VGMNJ_K( SQ4F70JL$$KV.1
M%][\._9WZA?3_"TN/2LOAL/;4W;CR <YQZS=@&/<EZZ!B\6M<H:A&6UQ*TYK
M_F*Y#PE/ PHDHW[9'07<5_9+M^=(N#VJ0K4,6,B@RIMQBC?^AN<+&WD;1"QR
M QAIV<A>G ]AK- M2R;JPADS#%E38XH[8AG>D6)NZ;HR:8UA\*<XI].<IQZ;
MJG)RQ<Q.Z7(@NF1%< <U/T -.'!9FBDA#A?'5SQ@5RP(R>^"7D99-MG:W RB
M*YYF<=+B!:%&1">\40YO;G&!22^1PM !\$O5!"SNY3JRX$&$5^E&\F*0ZP!8
M(AL%>(%/P5)JXU8Z>(3>=(#P0 &F3'#5KT!UXTT) QC$%5%?W/0"\Z6;1?!"
MPI0/,>$!ANFMO ,F!=0*R_'?'%A 7)XC;C^L=\=O)C TN@0RX9,XR8 ^20Q=
MRRX!O5Q#'VF O"]^2X7-&\>PYBE@$TJ_1%D(8X<V77D%S^[1WP=[FN$48K9P
M,'IK^7UNCWI)<49!!$(5B!31B V",)""(5="+2_C&4.3M$X[DR0(EZQ"$B S
M>""A;:/E_!.:=\%(IB2U*1MS#<6&T]5:(-Y#3G= @72+^YO*EG4200:0HU=K
MXWK$HX7O&XZ0[&(D QX&'$04A@="*RZTN:);P6!L.5Y(A?IPP&%I(N10XILL
M3R(<YAA;@'6[Y,B&0*:JE^9\RTEX(GAT$XQ!/P$'&:K=U15@PU$\X1[FVF R
M(=W]!&N?\#%>37J!R3UDUY"YXI(RN1#-3DU=%;.(\O$ &O  C4W$[)N=VCV]
M^:&Q\FB[ABXC7$#D<A1KR--U'L"KOX,HYZ054LX5U-5YPH:XX"CQ="N95!!X
MP1GX*E-<?U1#HQA^%#I=&>2@-SA>][7CR?O=Z-."4+5;-Q=Q&IHKL()@J9#G
M1G$Z01 #7; K9$&.1.+,"U#S"$:GENCVLD+BA.W: ;<K%=.Y!.,$"QGE";WM
M,Q<%M[B1#NP1)GL]-&8SCQM4 4T'2AI4]R#/&KPR8GBO9=:0Z#%G*"M^'C:$
MNM"F7LZ+2_0$IX,'F.8ICBB3G%4- V].$Y_Y"5A,NE(*.  'EX#N%0;F8Q3@
M' 0"(>*1QH:7:'8@,"G_;X[7KK$0B$<MB>O]2LV T&"&USL $]"]X9,@C4DV
MRT4%K#$*X'.I8=)Y&>O"Q_/#6M 4W@XJE\\3=[L*.U%G4$ 0U&X*! ,C5/NX
M1DM@*S0TJ#7'Q$MO^2 !ZS,5]Q>"'LQQ<=#52ZH2 GI3D ",6',.(#GK*MH@
M,2"_P& \&@K!2#- =VB@2*[<2GM5!" Z%1SKS?-Z:2N"#&%+%L<@?'A7(*R
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M./\*#8!91[$5HRBLY1##FY$(Z+LA8BQAF82'2YEX&".HA"P4X& ;E\'G)+7
MA3[G*5DM<[NB.LR?W8@60F#I<)NL*<8QI UF! S',DI*82SWDN)1H&T$T],F
M+.B-ZJYP[J#941<70P*R@:V@H"WVP_^;H\+ &JTDEP/%+Y!'1-@&6!]>SD%'
M%3MG/#[(MAMCP=@GQ8A<Q# P"<%SI*%>":67*E<LS,48&3KBQ(FU1M0ZM6AA
MJM: PL$XE6G$R/-1]^+O ^!A'WI^O2V7IS;+TBC09S)6BM8!9^IF%(-(R9<I
M(2"Q2<EN?'D6ZO%48*Q'!<6]:\;Y1!5IAV^2=@&1!1>X+)+&M]17TT*1(4H@
M\RQVA2F4X\.X8HC<!DX L+10%]@%# ,X/9D2PU60VB,N2(70@QX(/>RLL.6%
M;5\&<Q''YS(>QR@>1E)%"A8U\SHBW]_C:Z2B.A.SJ]%?!/K1<I!I'TN#3AJ1
M GK7!1VEMA;TH:14A&I :"%\?3;\$0C3(11!^3YTW^RI7*A%7'&G0.(C(;H,
MA"CTSP&F2(#(%#R-4J% V1B@;?"E1%9H!"@'BK9+J&:T:8I6YF%$+*EK-2-)
MO?+O=2?3S@**:(4!$NI#F\D5_:^SQI.O!UXDI$RE ?_QH:H"7][2?@$[EY8J
MS%0FH5-TRVC+*0%VQ:0L!N8R =;J?A1"'5FMU("ZY><#0#&8KJ40BR@ (8?L
M5JLC\'$]9C,$@Q7)]!A*(BDR,:L*&;^@T&> 0G\DMCD@GZSF>]539 PS>!Q7
M:XP1S#+P)IG/*Z.@,._8=7,,O13>FF3;*AT,]H(, QK1801JQD,P!>0'"-2L
M#R,U(;XG,1#_)F#2E!Q8+X!6,LH_(F&7H:*OS'TV83BE :&<ADC$9E1TR0:U
MA?%%$+H$F;4070'E5FZ+9A.G1'"Q]J.J%H+:B:C$X[:L0#HB1"*Q*I5T>'0X
M 8:T"MR"'501WKKV$:$QPCCR[ .QU.7*TQH%PO^NK1X-#WA&%@A0,VD&\R\$
M&W?MI:*D9E''+>7?4H/>IID#$<8HYT$:H PD+P6_- "L0!CEJ9+F*08Y LGS
MR(942BFC\@*#PP0+EAOP4H-CI6HMAHZ?BV5* ["RHK0AR$)1TB/P8;F2U?*M
MN<&G3,M<LA!1=947$*F-(!5,%P:@U#U4=I(L2^UT4$^GE+RZI&W\SQBK#9#]
M*,#+PND7\K" ":M.FU$H9.E+E/B"7W&)"H5;>EM8LP;CR-):M%3F?!8)L(N(
M'_ARF' N;+"H=Z*<1^KFN&.5"B"I0I-#@P@E9&A>5>XYZ[@TD+IXL?M R"%-
MHYS?GI@$V4H0I1VD-"Y!7"\SWRU\6'KGN-*/1Z5^O/>I?AVSZ]OO2\Z@8GE&
MB3<<;YPG+D_5(H&!3S&H+#9A&/IC6Z?W8.4T5'W*'@"@AR2L6MCAAI0N2HPV
M_' 4TYTHRHGZC;(A0\=%T)WM/\L::2K2$;F@/>YRK-@5"],6.Q#T1HJ(?IAI
MJN$E4.JSD'$T+56@A6,]8+%5?4:P6YA'$$"A,C&R!K.<;M5PE6B:;4AB;8%2
MI9--A;)8BT;2(HP6:C)>_UE^*.(. C@H2[12R,D*PUO \+.%5J)*=0RC$@YI
MPB=@\!#(%GAM$"=)?(VIXH-F&!VF)G>,8"'Y),Y$I6@Y;^4JB(4E%?5R--24
M\TM$;;@U16*(<H2%NA1O4OENBE#;Q>K-)L03W@A!>-G8&!F1$@"17+L0:WE]
M=A4G!; 5J&H)F<J$]?QB'T2E\Z<6$:&RN$P$!/$8@]2?+F>"&@T&Y%N.@@'E
M3Y8SAR 0CX:BI+I6FH!.W17E*U6E\&- I/*$EK?AJ*)7Q#TLK\8S$P3&B<=C
MC$V2EP;  [<,(5(?,]I24]8_L*GT@ BXN07W4,5>D&+ 6N0H$=-AL0-H?EDP
MC(!Z+I*&]C&@S:K+\+H AX4_US#?ZPB7@&UD3DUPI+IXE3WP%:.@B$C,D(V^
MH?P^Y8WEM@Q6%KF4K^_6=:[\MC1AZ-BFLV(/;*+@SF/AE=:^QERB]'*#F<B?
M6G-_N>0,C]?\_+G((/Z0X;:25;I[9;P6VAP54![E*1J%F+;+)KQ@[\*E]G)7
M</.2MH"80I_$$2BV?"+"C54=6U#4!1/&1WS/TI&8*"P0PO;7JO+*+$8$1),Q
M"Q)+BG2*NE*OYOK!%VWY!?KCY%^BAXL[(U Q<*0:*C3A%4JR%M(KX24J=.&"
MQY2VQYK^H8Q9);5X!'1FR<[(,=)$(5'C8)5RX5YU7B_J&&0NQL4KNJX50E&\
MG04)A4AX5?DCSD@I2R:@Z>Y*39,;F6)%BDM!A0D9&RD#@ZQ2,VD]!_*J]UH1
M-<JU"(E2;&Y"W4O51K1S@W9R_+,A1@ODHNEWL#"-08D.:&-$6L8H%_+4U]E2
M:C900#@M"BJ4FSF6M+J.J@T)6'.5%RBNV^Q:68@@( D'9U*4@H%(9PUZST2%
M(T1=E-,/A444V@D#BD(,9'@QJO-M/2((X[P]S*A*TR:V'0C+5JBY*Q[&$YI
M97\I@D8L5$Z*M*V<4JGTI.I8:62UX9036\9U<SJK*0TU?=?,8TH]G0MD4N&;
M@H'%6QC1Q%YJ/N]"!(O&6QJD)0,M2S Q*%UNHU%)]=X:.OR!,4*JX:(D8"U(
MVBB1^:6*&5:! RP762V ."<#=1&IXD5T((3T@-*YX#FT,UZN$EX*#1Z[:ER
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MSVJ'EZF5D2F59&VNL"ZI6.-ZC[2'N0$3Q7[-0F.[XG ]@8#00M$(<50U@J#
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M+H);ZWZW]N8@]J;P?Z-L'+[Y_U!+ P04    "  (G:I2@GUHCHD"  "'"0
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MO>^Q(W>07Q#WSL6;><,==9#6!?L<=I=K,+Q=M_TG-W ;V%[NB]%/4$L#!!0
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M=?>_?[1ZVGKS\_6ZG'W!IBWJ:G_.=]E\AE6H8U&=[\__.'L'9O[SP<[.FW\
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M,#(Q,#4P-BYH=&U02P$"% ,4    "  (G:I2@GUHCHD"  "'"0  $
M        @ $;-   96AC+3(P,C$P-3 V+GAS9%!+ 0(4 Q0    (  B=JE)D
M@!GRA $  -,"   4              "  =(V  !E:&,M,C R,3 U,#9?8V%L
M+GAM;%!+ 0(4 Q0    (  B=JE([3,P>" (  '@&   4              "
M 8@X  !E:&,M,C R,3 U,#9?9&5F+GAM;%!+ 0(4 Q0    (  B=JE*$;9 C
M.@H  *)=   4              "  <(Z  !E:&,M,C R,3 U,#9?;&%B+GAM
M;%!+ 0(4 Q0    (  B=JE*^%- 7MP8  ',Q   4              "  2Y%
L  !E:&,M,C R,3 U,#9?<')E+GAM;%!+!08     !@ & (0!   73      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
